Danaher Corporation vs JD.Com Inc — how do they compare? Danaher Corporation trades at $217.88 (market cap $153.60B), while JD.Com Inc trades at $26.98 (market cap $36.51B). The key difference: Danaher Corporation is far larger — about 4.2× JD.Com Inc's market cap, and JD.Com Inc pays the higher dividend (3.7%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and JD.Com Inc for 85 Days on average.
| DHR | JD | |
|---|---|---|
Market Cap | $153.60B | $36.51B |
Volume | 3,974,063 | 7,051,146 |
Sector | Health | Consumer Cyclical |
52-Week High | $242.05 | $34.53 |
52-Week Low | $161.91 | $25.19 |
Typical Hold Time | 69 Days | 85 Days |
Enterprise Value | $175.81B | $19.16B |
Dividend Yield | 0.73% | 3.7% |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $217.46, up 0.88% on the day, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue grew to $24.57B in 2025, though net margins have compressed from historical highs. A quarterly dividend of $0.40 was declared, payable in October 2026.
The outlook remains positive given earnings momentum and institutional accumulation, but valuation multiples are elevated. Risks include margin pressure and high capital expenditure in 2026. The consensus price target of $230.31 implies modest upside, supported by 70% buy ratings from analysts.
JD.com is trading at $27.03, up 2.0% today, with strong analyst support showing 32 buy ratings versus just 1 sell. The stock demonstrates solid fundamentals with a low P/E of 17.98 and P/S of 0.2, trading below its $35.86 consensus price target. Recent earnings have consistently beaten expectations, though revenue growth has slowed in 2025 with net income margin declining to 1.13%. The company maintains a robust balance sheet with $234 billion in cash and is pursuing strategic acquisitions including the pending Ceconomy deal.
JD.com presents a compelling value opportunity with significant upside potential to analyst targets, supported by strong cash flow generation and consistent earnings beats. However, investors face risks from slowing revenue growth, regulatory scrutiny of international expansion, and competitive pressures in the Chinese e-commerce sector. The stock's current valuation appears attractive relative to peers, but requires monitoring of execution on strategic initiatives.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →JD.com is China's second-largest e-commerce company after Alibaba in terms of gross merchandise volume, offering a wide selection of authentic products at competitive prices, with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
Read more on JD →